| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |